Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma is a research paper published in PLoS ONE (2013). On theSindex it has a DataRank of 1.1. It has been cited 29 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0.550
From 18 citing papers with measurable signal
NCI NIH HHS
Grant: T32CA091078
NCI NIH HHS
Grant: K08CA118178
NCI NIH HHS
Grant: P01 CA071933
FWCI
1.48
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals